Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Medtronic reiterated and affirmed its previously issued financial guidance for the first quarter of the 2025 fiscal year that ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. The company’s diabetes segment lags behind competitors like DexCom and Abbott due to ...

To educate people on importance of being ethically conscious, aware, choosing the right path in case of conflict of interest and speak-up without fear when they see anything unethical. To make it ...

Medtronic has issued a second alert letter to ... The new alert updates a previous one issued in July. On October 4, 2024 (and announced by FDA on October 17), the company issued an “Urgent ...

While hardware revenue is continuing to decline - 58% to $42.4 million in Q3/24 - revenue ... and also in comparison to Medtronic's Guardian. Now we could argue that Dexcom might be able to ...

Shares of Medtronic PLC MDT inched 0.56% higher to $88.26 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...

Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the length of their battery life. The Dublin-based medical-device maker said Friday that customers of its ...